Find your next paid study

Actual pay is set by the research site.

Mayo ClinicNCT06106269

Health Communications for Adults Smoking Nondaily

The goal of this study is to develop smoking health risk messaging targeted to adults who smoke some days, but not smoke every day (nondaily). The main purpose…

Smoking Cessation

Bethany Shorey Fennell, PhDNCT07296848

~$10 – $1,125

Actual pay is set by the research site.

Phase 2

Phase II Open-label, Multi-center Study of Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma (mUM) With Integrated Circulating Tumor DNA (ctDNA) Biomarker (TARGET-tebe)

This is a phase II open-label, single-arm, multi-center study of tebentafusp in HLA- A\*0201 positive previously untreated (1L) untreated metastatic uveal mela…

Uveal Melanoma

End Stage Renal Disease (ESRD)Volume Overload

~$75 – $3,000

Actual pay is set by the research site.

Diwakar DavarNCT06070012

Blood Volume Monitoring Via Critline in Volume Overload: Hospitalization and Readmission

The investigators are examining how adding relative blood volume monitoring (RBVM) to the best clinical practice affects outcomes (length of stay and rehospita…

Massachusetts General HospitalNCT07866872

Actual pay is set by the research site.

Phase 2

Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma (REDUCE-30)

This is a single-arm, phase II study that is designed to investigate nodal and primary tumor CTV dose de-escalation (30 Gy) in HPV positive oropharyngeal cance…

Oropharyngeal Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma

~$75 – $3,000

Actual pay is set by the research site.

Sara MedekNCT07497607

Phase 3

aPCC and Emicizumab Safety Study in Congenital Hemophilia A Patients With Inhibitors (SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis)

The purpose of the aPCC-emicizumab safety study is to investigate the hemostatic efficacy as measured by thrombin generation, of a low personalized dose of aPC…

Hemophilia A

Emory UniversityNCT04563520

~$50 – $1,500

Actual pay is set by the research site.

Phase 1

A Molecularly Driven Phase 1b Dose Escalation and Dose Expansion Study of the DNA-PK Inhibitor Peposertib (M3814) in Combination With the ATR Inhibitor Tuvusertib (M1774)

This phase I trial tests the safety, side effects and best dose of peposertib (M3814) in combination with tuvusertib (M1774) in treating patients with solid tu…

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm

National Cancer Institute (NCI)NCT05687136

~$150 – $2,700

Actual pay is set by the research site.

Phase 2

A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

This is a randomized, double-blind, placebo-controlled trial in de novo kidney transplant patients to determine if the addition of fingolimod (brand name Gilen…

Interstitial FibrosisKidney Transplant; ComplicationsKidney Transplant Rejection+4 more

The Methodist Hospital Research InstituteNCT05285878

~$75 – $2,000

Actual pay is set by the research site.

Implementation ScienceInformed ConsentNeonatal Screening

Implementing a Novel Consent Process for Biospecimen Research After Newborn Screening in Hospitals Serving Diverse Patients

The purpose of this study is to implement an electronic consent education process for the retention and research use of residual dried bloodspots at four hospi…

~$10 – $1,125

Actual pay is set by the research site.

Erin RothwellNCT06192511

Mechanical Ventilation Complication

A Phase III Randomized Trial Comparing the Effects of Volume Support and Assist Control Mode Ventilation on Ventilator-Free Days and Diaphragmatic Atrophy

The objective of the study is to determine how controlled mode ventilation and support mode ventilation impact ventilator-free days and diaphragmatic atrophy.

University of ChicagoNCT03901924

Actual pay is set by the research site.

A Single-Blind Randomized Clinical Trial to Evaluate the Efficacy of High Vector Electrokinetics (HiVE), A Form of Peripheral Magnetic Stimulation, In Treatment of Chronic Back Pain

The goal of this study is to see if a new way to treat back pain without the use of medications is effective. We plan use Transcranial Magnetic Stimulation (TM…

Lower Back Pain Chronic

~$10 – $1,125

Actual pay is set by the research site.

Joe X. ZhangNCT07652944

Food As Medicine to Reduce CKD Burden in Health Disparity Populations

Healthy eating plays an important role in kidney and heart health, and programs that use food as medicine can help improve diet and overall health, but the bes…

Chronic Kidney Disease